| Date | Form | Description | Docs | XBRL | Pages |
| 09/11/06 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
30 | |
| 06/09/06 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
27 | |
| 03/10/06 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
28 | |
| 09/09/05 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
25 | |
| 06/09/05 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
22 | |
| 03/10/05 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
24 | |
| 09/02/04 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
28 | |
| 06/01/04 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
33 | |
| 02/27/04 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
24 | |
| 09/15/03 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
21 |
Latest News & Events
Anixa Biosciences and OntoChem Have Synthesized Four Potential Covid-19 Drugs for Testing in Biological Assays
Read More...Anixa Biosciences and OntoChem Announce Discovery of First Covid-19 Therapeutic Candidate
Read More...Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Biomarker Insights Highlighting Cchek™ Liquid Biopsy Technology
Read More...